The future of affordable cancer immunotherapy.

Eventually, yes.

Look at every other tech, given enough time, the price becomes adorable. Considering this is a “generalized” cure to cancer, it’s likely highly profitable to get it to the point where ever body can access it. “Cheap”? No, but “affordable”.